Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tricida files for $150M IPO to fund kidney disease drug approval

fiercebiotechJune 11, 2018

Tag: Tricida , IPO , disease drug

PharmaSources Customer Service